Claim OwnershipThe Promise of Personalized Medicine
Subscribed: 2Played: 9
Subscribe
© 2025 The Promise of Personalized Medicine
Description
There is no personalized medicine without a diagnostic test to help in the process. The Promise of Personalized Medicine is a podcast that explores the process of creating more personalized medicine and the Medical Directors who ensure that the right care is being delivered to us all. Season 1 will focus on understanding best practices by using the Blueprint of Success format as a template for labs to use when trying to get their novel diagnostic test approved by health plans. This is The Promise of Personalized Medicine.
31 Episodes
Reverse
In this episode of The Promise of Personalized Medicine, host Perry Dimas recaps highlights from the recent Diagnostics Conference in Napa—a gathering that brought together leaders and innovators shaping the future of precision medicine. Perry shares key takeaways from the event, including thought-provoking discussions on data aggregation for faster industry adoption, insights from MetaCensus on collaborative progress, and a critical legal update from Debbie Parish of Parish Law. He also refl...
In this episode of The Promise of Personalized Medicine, Perry sits down Eugean Jimanwall, Senior Research Analyst for Medical Policy & Technology Evaluation at Independence Blue Cross’ Medical & Claim Payment Policy Department within Facilitated Health Networks and Medical Affairs. He is a seasoned expert with more than 15 years of experience in medical policy and health technology assessment. Together, they unpack the evolving world of personalized and precision medicine—what it...
In this episode of The Promise of Personalized Medicine, Perry sits down with Dr. Neetu Sharma to explore the evolving world of precision medicine and how it’s transforming patient care. From the role of genetics and biomarkers in tailoring treatment to the importance of lifestyle, environment, and early intervention, Dr. Sharma offers a holistic view of what personalized medicine truly means. They discuss real-world applications, including chronic kidney disease, and how genetic testing can ...
In this episode of The Promise of Personalized Medicine, Perry sits down with Dr. Ryan Nelson, to explore the evolving and sometimes misunderstood world of personalized medicine. With years of hands-on experience, Dr. Nelson offers a refreshingly nuanced definition—one that goes beyond genetics to include biomarkers, digital tools, and system-wide collaboration for predictive, preventative, and precisely tailored care. We dive deep into: the challenges and slow adoption of pharmacogenet...
In this episode of The Promise of Personalized Medicine, Perry sits down with Jonathan Romanowksy, Co-Founder and Chief Business Officer at Inflammatix, Inc. With years of experience in the field, Jonathan shares insights into how personalized medicine is expanding beyond oncology and transplantation into new areas such as infectious diseases, neurology, and immunology. They dive into the challenges and opportunities of bringing innovative diagnostic tools to market, ensuring clinical a...
In this episode of The Promise of Personalized Medicine, Perry sits down with Sarah Clancey Overton, Director of Revenue Cycle Management at Velsera. They discuss how genetic profiling is transforming healthcare—enabling targeted treatments, improving prognostic tools, and even opening doors for disease prevention. The conversation highlights the critical role of diagnostic testing in precision medicine, the increasing collaboration between pharmaceutical companies and labs, and the challenge...
In this year-end wrap-up episode of The Promise of Personalized Medicine, host, Perry is the guest this week and he’s joined by his producer, Angela! They reflect on the significant shifts and trends that defined 2024 in the healthcare and diagnostics industries. Join as they explore FDA regulatory developments, state-level biomarker laws, and innovations shaping personalized medicine. The fantastic lineup of guests from the past year are celebrated—Beth Davis, Wren Gregory, Dr. Sandra ...
In this episode of The Promise of Personalized Medicine, Perry sits down with Dr. Sherie Smalley to explore the nuanced challenges and opportunities in today’s healthcare landscape. Dr. Smalley shares her unique perspective as a physician and medical director, shedding light on the complexities of aligning patient care, financial responsibility, and clinical decision-making. The conversation dives into the misalignment of incentives within the healthcare system, the critical need for cost tra...
Today we sit with Tyler O’Malley, an expert in the evolving fields of personalized and precision medicine, to explore how advancements in diagnostics are transforming patient care. Tyler shares his vision for healthcare that shifts away from broad-based disease management toward more individualized treatment, especially in challenging fields like autoimmune diseases. He discusses the role of artificial intelligence in leveraging vast data for actionable insights, which enable doctors to take ...
Imagine going to the doctor and knowing your treatment is designed just for you—tailored to your unique biology, lifestyle, and even your genetic code. That’s the promise of personalized medicine. But with all the advancements in precision healthcare, are we truly getting more personalized care, or are we just layering new technologies onto old practices? Today, we're diving deep into this tension between cutting-edge innovation and traditional healthcare, exploring what it really means to tr...
The fight for reimbursement often feels like navigating a maze. From lengthy appeals to prior authorizations, labs and healthcare providers must balance innovation with complex payer policies. But what if this process could be less adversarial, more collaborative, and streamlined with the help of cutting-edge technology? Our guest today is Tom Cronin, Senior Vice President, Revenue Cycle Strategy & Analytics at Quadax. Quadax is the leading and trusted healthcare partner delivering revenu...
In personalized medicine, where data, technology, and patient care converge, success depends on embracing change and collaboration. As our guest puts it, 'At the end of the day, it's all about patient care. So if we have to make some changes in order to make a positive change for them, let's do that.' Today’s guest is Rennie Quarles, Sr. Director Biopharma Commercialization. She shares insights on the balance between maintaining exclusivity and fostering open access to new treatments, emphasi...
Picture this: You walk into a doctor's office, and instead of a one-size-fits-all prescription, you're handed a treatment plan designed specifically for your genetic makeup. This isn't science fiction; it's the groundbreaking promise of personalized medicine, where cutting-edge technology meets the intricacies of human biology to provide precise and effective healthcare solutions. Today’s guest is Deb Phippard, Chief Scientific Officer at Precision for Medicine. They delve into the fundamenta...
Personalized medicine still has so much potential. With the need for greater adoption and further advancement becoming more apparent, this conversation is necessary. Today's guest is Dr. Sandy Milligan, the President of Research & Development, Laboratory Operations, IT and HR at Aspira Women’s Health. Dr. Milligan explains the nuances of personalized medicine, defining it as an individualized approach to healthcare that leverages precise diagnostics based on omics data analytics. We explo...
Clinical research plays a critical role in advancing medical treatments. Today's guest is Dr. Wren Gregory, the Director of Laboratory Operations and Clinical Research at Precision Genetics. Join us as Dr. Wren describes her responsibilities in overseeing lab documentation, compliance, and team mentorship, ensuring smooth operations at Precision Genetics’ facilities in Greenville and Charleston. She also discusses the critical role of clinical champions in advancing precision medicine, partic...
Progress and transformation–are two words we definitely want to be associated with our US Healthcare. Today’s guest, Beth Davis, addresses the significant strides made in digital healthcare and smart technologies, ranging from wearable devices to implantable devices that monitor vital signs and manage chronic conditions like diabetes. She emphasizes the positive impact on test turnaround time, treatment plans, and patient care management facilitated by advancements in biomarkers, diag...
The tables are turned on our regular host, Perry Dimas, and this week–he becomes the guest! Our Producer, Angela, takes the hosting seat and asks Perry all those questions you’ve been wanting to know. Questions like: What are YOUR thoughts on Personalized Medicine?What has made Season 2 special, so far?What is the newest piece of information that you believe would help laboratories as they’re developing their tests in 2024? There’s also an insightful game entitled: “How Well Do...
Our DNA holds the keys to understanding our health and well-being. Our guest today is Jill Davies, CEO at Genome Medical. She emphasizes the crucial role of genetic counselors in deciphering complex genetic information for individuals, offering tailored guidance on healthcare decisions. Jill introduces the concept of genetic counseling assistants, streamlining the process and allowing genetic counselors to focus on the most critical aspects of patient care. The conversation also dives into: S...
Coding in the world of medical tests and personalized medicine may not be the most scintillating topic, but it's a critical puzzle piece that can make or break the seamless delivery of healthcare services. Our guest today is Dr. James Almas, the National Medical Director for Clinical Effectiveness at Labcorp, who provides an in-depth exploration of the complexities of medical coding in the context of personalized medicine. He shares deep insights into the intricacies of medical coding, ...
The goal of personalized medicine is to pinpoint the most effective treatments and reduce the morbidity and toxicity associated with unnecessary therapies. One of the major challenges in the field is securing reimbursement for personalized medicine services. While Medicare often leads the way in adopting new approaches, other payers vary in their criteria, making it a complex landscape to navigate. Our guest today is Matt Mega, the Senior Vice President of Market Access at Natera. He emphas...
Comments
Download from Google Play
Download from App Store
United States